Year: 2017

Liquidity Agreement -1 December Paris, France and Cambridge, UK – 1 December 2017 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by

Novacyt Technology Fast 50 Award 2017 ENG Paris, France and Cambridge, UK – 7 November 2017 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces it has won, for the second consecutive year, the Ile-de-France award of the Deloitte Technology Fast 50 French programme, an initiative that rewards fast

Settlement and redemption of convertible bonds with Yorkville ENG Removes potentially dilutive instrument Strengthened balance sheet supports future growth